Unknown

Dataset Information

0

Femtosecond Laser-Assisted Cataract Surgery Versus Phacoemulsification Cataract Surgery (FACT): A Randomized Noninferiority Trial.


ABSTRACT: PURPOSE:To report the 3-month results of a randomized trial (Femtosecond Laser-Assisted Cataract Trial [FACT]) comparing femtosecond laser-assisted cataract surgery (FLACS) with standard phacoemulsification cataract surgery (PCS). DESIGN:Multicenter, randomized controlled trial funded by the UK National Institute of Health Research (HTA 13/04/46/). PARTICIPANTS:Seven hundred eighty-five patients with age-related cataract. METHODS:This trial took place in 3 hospitals in the UK National Health Service (NHS). Randomization (1:1) was stratified by site, surgeon, and 1 or both eyes eligible using a secure web-based system. Postoperative assessments were masked to the allocated intervention. The primary outcome was unaided distance visual acuity (UDVA) in the study eye at 3 months. Secondary outcomes included corrected distance visual acuity, complications, and patient-reported outcomes measures. The noninferiority margin was 0.1 logarithm of the minimum angle of resolution (logMAR). ISRCTN.com registry, number ISRCTN77602616. MAIN OUTCOME MEASURES:We enrolled 785 participants between May 2015 and September 2017 and randomly assigned 392 to FLACS and 393 to PCS. At 3 months postoperatively, mean UDVA difference between treatment arms was -0.01 logMAR (-0.05 to 0.03), and mean corrected distance visual acuity difference was -0.01 logMAR (95% confidence interval [CI], -0.05 to 0.02). Seventy-one percent of both FLACS and PCS cases were within ±0.5 diopters (D) of the refractive target, and 93% of FLACS and 92% of PCS cases were within ±1.0 D. There were 2 posterior capsule tears in the PCS arm and none in the FLACS arm. There were no significant differences between arms for any secondary outcome. CONCLUSIONS:Femtosecond laser-assisted cataract surgery is not inferior to conventional PCS surgery 3 months after surgery. Both methods are as good in terms of vision, patient-reported health, and safety outcomes at 3 months. Longer-term outcomes of the clinical effectiveness and cost-effectiveness are awaited.

SUBMITTER: Day AC 

PROVIDER: S-EPMC7397499 | biostudies-literature | 2020 Aug

REPOSITORIES: biostudies-literature

altmetric image

Publications

Femtosecond Laser-Assisted Cataract Surgery Versus Phacoemulsification Cataract Surgery (FACT): A Randomized Noninferiority Trial.

Day Alexander C AC   Burr Jennifer M JM   Bennett Kate K   Bunce Catey C   Doré Caroline J CJ   Rubin Gary S GS   Nanavaty Mayank A MA   Balaggan Kamaljit S KS   Wilkins Mark R MR  

Ophthalmology 20200303 8


<h4>Purpose</h4>To report the 3-month results of a randomized trial (Femtosecond Laser-Assisted Cataract Trial [FACT]) comparing femtosecond laser-assisted cataract surgery (FLACS) with standard phacoemulsification cataract surgery (PCS).<h4>Design</h4>Multicenter, randomized controlled trial funded by the UK National Institute of Health Research (HTA 13/04/46/).<h4>Participants</h4>Seven hundred eighty-five patients with age-related cataract.<h4>Methods</h4>This trial took place in 3 hospitals  ...[more]

Similar Datasets

| S-EPMC8718704 | biostudies-literature
| S-EPMC4542520 | biostudies-literature
| S-EPMC6995244 | biostudies-literature
| S-EPMC4663449 | biostudies-other
| S-EPMC7524180 | biostudies-literature
| S-EPMC4801419 | biostudies-literature
| S-EPMC6616539 | biostudies-literature
| S-EPMC7393470 | biostudies-literature
| S-EPMC8542738 | biostudies-literature
| S-EPMC5855332 | biostudies-other